Physician profile
Brian Christopher Ruhle
NPI 1760863930
$5,358.80
in general payments reported to CMS, 2019-2025
7 companies · $2,036 in 2025
The $2,036 reported for 2025 was more than what 82% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $368 · 2020: $305 · 2021: $1,064 · 2022: $1,144 · 2023: $28.00 · 2024: $414 · 2025: $2,036.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $1,500 · Travel and Lodging: $627 · Food and Beverage: $351.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $1,500.00 |
| Travel and Lodging | $626.85 |
| Food and Beverage | $350.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $4,726.66 | 2019-2025 | Da Vinci Surgical System |
| Medical Device Business Services, INC. | $336.92 | 2020-2021 | |
| Davol INC. | $173.12 | 2025 | Phasix Mesh, Arista |
| Tela Bio, INC. | $51.45 | 2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Medtronic, INC. | $33.07 | 2025 | Transorb |
| Virtual Incision Corporation | $21.00 | 2024 | Mira |
| Apollo Endosurgery US INC | $16.58 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Ruhle listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.